Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,422 GBX | +0.73% | +3.02% | +17.11% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.11% | 239B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+8.08% | 204B | |
-7.61% | 198B | |
+8.62% | 168B | |
+4.52% | 125B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : Bernstein reiterates its Buy rating